Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
37.87
+3.06 (8.79%)
At close: Jun 24, 2026, 4:00 PM EDT
37.82
-0.05 (-0.13%)
Pre-market: Jun 25, 2026, 5:27 AM EDT
Viking Therapeutics Employees
Viking Therapeutics had 59 employees as of March 31, 2026. The number of employees increased by 13 or 28.26% compared to the same quarter last year.
Employees
59
Change
13
Growth
28.26%
Revenue / Employee
n/a
Profits / Employee
-$8,005,678
Market Cap
4.40B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| Denali Therapeutics | 507 |
| Relay Therapeutics | 193 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| Tango Therapeutics | 137 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
VKTX News
- 18 hours ago - Viking catalysts include VK3019, VK2735 readouts in Q3, says Raymond James - TheFly
- 22 hours ago - Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019 - TheFly
- 22 hours ago - Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults - PRNewsWire
- 9 days ago - Viking Therapeutics management to meet with B. Riley - TheFly
- 13 days ago - Viking Therapeutics names Hubert Chen, M.D., as Chief Medical Officer - TheFly
- 13 days ago - Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D. - PRNewsWire
- 17 days ago - Viking Therapeutics Slides: Corporate presentation - Filings
- 20 days ago - Viking Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts